9 unknown. 9 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Unknown 9 |
| Phase 2 | 2 | Unknown 2 |
Follow Small Cell Lung Cancer: new trials by email Literature Review of Small Cell Lung Cancer trials Research Report on Small Cell Lung Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Camrelizumab Combined With Apatinib, Etoposide and Cisplatin Treat Small-cell Lung Cancer. Camrelizumab combined with Apatinib, Etoposide and Cisplatin - Lung Neoplasm, Small Cell Lung Cancer | Phase 3 | Unknown | Fuzhou General Hospital | 45 | 2020-08-01 | 2021-02-08 |
| Study of Anlotinib Hydrochloride Capsule in Subjects With Small Cell Lung Cancer Anlotinib, Placebos, Topotecan - Small Cell Lung Cancer | Phase 3 | Unknown | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 184 | 2019-10-31 | 2019-08-29 |
| Anlotinib Combined With Sintilimab as Second-line Treatment or Beyond in Patients With Small Cell Lung Cancer Anlotinib Hydrochloride - Small Cell Lung Cancer | Phase 2 / Phase 3 | Unknown | Changzhou Cancer Hospital of Soochow University | 40 | 2019-05-08 | 2020-01-06 |
| Mesylate Apatinib Combined With Irinotecan in Treatment of Recurrent Small Cell Lung Cancer Apatinib, Irinotecan - Small Cell Lung Cancer | Phase 3 | Unknown | Beijing Chest Hospital | 90 | 2018-09-08 | 2018-08-29 |
| Apatinib as the Maintenance Therapy for Extensive Stage Small Cell Lung Cancer After Combined With Etoposide/Cisplatin apatinib;etoposide and cisplatin, placebo;etoposide and cisplatin - Small Cell Lung Cancer | Phase 3 | Unknown | Third Military Medical University | 100 | 2016-09-01 | 2016-08-24 |
| SCLC on the 2nd Line With Relapsed After Response to Chemotherapy GFPC 01-2013 Carboplatin, Etoposide, Topotecan - Small Cell Lung Cancer | Phase 3 | Unknown | University Hospital, Angers | 164 | 2013-07-01 | 2016-04-25 |
| STAD-1 Small Cell Lung Cancer Toxicity Adjusted Dosing Study cisplatin, etoposide - Small Cell Lung Cancer | Phase 3 | Unknown | National Cancer Institute, Naples | 160 | 2007-09-01 | 2023-03-24 |
| Study of Picoplatin Efficacy After Relapse picoplatin, best supportive care - Small Cell Lung Cancer | Phase 3 | Unknown | Poniard Pharmaceuticals | 399 | 2007-04-01 | 2009-04-14 |
| A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage Carboplatin plus Irinotecan vs Carboplatin plus Etoposide - Small Cell Lung Cancer | Phase 2 / Phase 3 | Unknown | Charite University, Berlin, Germany | 286 | 2001-10-01 | 2006-02-14 |
Small Cell Lung Carcinoma (9) · Lung Neoplasms (1)
Bronchial Neoplasms (9) · Carcinoma, Bronchogenic (9) · Lung Diseases (9) · Neoplasms (9) · Neoplasms by Site (9) · Respiratory Tract Diseases (9) · Respiratory Tract Neoplasms (9) · Thoracic Neoplasms (9) · Lung Neoplasms (8)
Etoposide (4) · Cisplatin (3) · Carboplatin (2) · Topotecan (2) · apatinib (2) · Irinotecan (1) · Tomography, X-Ray Computed (1) · amminedichloro(2-methylpyridine)platinum(II) (1) · anlotinib (1) · sintilimab (1)
Beijing Chest Hospital (1) · Changzhou Cancer Hospital of Soochow University (1) · Charite University, Berlin, Germany (1) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1) · Fuzhou General Hospital (1) · National Cancer Institute, Naples (1) · Poniard Pharmaceuticals (1) · Third Military Medical University (1) · University Hospital, Angers (1)
China (3) · Argentina (1) · Belarus (1) · Bosnia and Herzegovina (1) · Bulgaria (1) · Chile (1) · Croatia (1) · France (1) · Germany (1) · Hungary (1) · India (1) · Italy (1) · Latvia (1) · Montenegro (1) · Poland (1)
Cesare Gridelli, M.D. (1) · Ciro Gallo, M.D., Ph.D (1) · Dr. Hazel Breitz, M.D. (1) · Francesco Perrone, M.D., Ph.D (1) · Massimo Di Maio, M.D. (1) · Tong Zhou (1) · Ulrich Keilholz, MD (1) · Wang Dong, PH.D. (1) · Xiong Chen (1)